Myomo (MYO) Other Non Operating Income (2016 - 2025)
Myomo's (MYO) quarterly Other Non Operating Income came in at -$9743.0 in Q3 2025, down 112.82% on a YoY basis from $76020.0 in Q3 2024, and down 109.14% quarter-over-quarter from $106549.0 in Q2 2025.
Powered by 
Analysis
Myomo (MYO) Other Non Operating Income (2016 - 2025) Analysis & Trends
Myomo (MYO) has reported Other Non Operating Income for 10 consecutive years, with -$9743.0 the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Other Non Operating Income fell 112.82% year-over-year to -$9743.0; the trailing twelve-month figure through Sep 2025 stood at $358828.0 (down 0.99% YoY), and the FY2024 full-year result was $388586.0, up 61.92% from the prior year.
- Other Non Operating Income declined to -$9743.0 in Q3 2025 per MYO's latest filing, from $106549.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $191991.0 in Q1 2025 and bottomed at -$48994.0 in Q4 2022.
- Historically, Other Non Operating Income has averaged $46013.4 across 5 years, with a median of $43871.0 in 2023.
- The sharpest annual moves came in 2022 and 2023: Other Non Operating Income slumped 852.63% in 2022, then soared 132748.08% in 2023.
- Over 5 years, Other Non Operating Income stood at -$5143.0 in 2021, then plunged by 852.63% to -$48994.0 in 2022, then jumped by 189.54% to $43871.0 in 2023, then soared by 59.63% to $70031.0 in 2024, then slumped by 113.91% to -$9743.0 in 2025.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$9743.0, $106549.0, and $191991.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -9,743.00 |
| Jun 30, 2025 | 106,549.00 |
| Mar 31, 2025 | 191,991.00 |
| Dec 31, 2024 | 70,031.00 |
| Sep 30, 2024 | 76,020.00 |
| Jun 30, 2024 | 107,242.00 |
| Mar 31, 2024 | 135,293.00 |
| Dec 31, 2023 | 43,871.00 |
| Sep 30, 2023 | 70,124.00 |
| Jun 30, 2023 | 85,294.00 |
| Mar 31, 2023 | 69,081.00 |
| Dec 31, 2022 | -48,994.00 |
| Sep 30, 2022 | 12,307.00 |
| Jun 30, 2022 | -19,528.00 |
| Mar 31, 2022 | 52.00 |
| Dec 31, 2021 | -5,143.00 |
| Sep 30, 2021 | -4,055.00 |
| Jun 30, 2021 | -6,018.00 |
| Mar 31, 2021 | -119.00 |
| Dec 31, 2020 | -14,653.00 |